Burning mouth syndrome
Abstract
Introduction: Burning mouth syndrome mainly affects women, particularly after the menopause, when its prevalence may be 18% to 33%.
Methods and outcomes: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for burning mouth syndrome? We searched: Medline, Embase, The Cochrane Library, and other important databases up to November 2009 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results: We found 15 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
Conclusions: In this systematic review we present information relating to the effectiveness and safety of the following interventions: anaesthetics (local), antidepressants, benzodiazepines (topical clonazepam), benzydamine hydrochloride, cognitive behavioural therapy (CBT), dietary supplements, and hormone replacement therapy (HRT) in postmenopausal women.
References
-
- Fox H. Burning tongue glossodynia. N Y State J Med 1935;35:881–884.
-
- Zakrzewska JM. The burning mouth syndrome remains an enigma. Pain 1995;62:253–257. - PubMed
-
- Van der Waal I. The burning mouth syndrome. 1st ed. Copenhagen: Munksgaard, 1990.
-
- Merksey H, Bogduk N, eds. Classification of chronic pain. 2nd ed. Seattle: International Association for the Study of Pain Press, 1994.
-
- Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999;28:350–354. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous